메뉴 건너뛰기




Volumn 22, Issue 2, 2012, Pages 797-800

Tricyclic 3,4-dihydropyrimidine-2-thione derivatives as potent TRPA1 antagonists

Author keywords

Antagonist; Biginelli; TRPA1

Indexed keywords

4 PHENYL 2 THIOXO 1,2,3,4 TETRAHYDROINDENO[1,2 D]PYRIMIDIN 5 ONE; THIOUREA DERIVATIVE; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1 ANTAGONIST; TRANSIENT RECEPTOR POTENTIAL CHANNEL AFFECTING AGENT; UNCLASSIFIED DRUG;

EID: 84855668536     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2011.12.068     Document Type: Article
Times cited : (51)

References (24)
  • 22
    • 77957890633 scopus 로고    scopus 로고
    • 2+ fluorometric measurements on hTRPA1 and rTRPA1 inducible HEK293 cells. All data shown for the hTRPA1 receptor were derived using the potent, human specific hTRPA1 agonist 5H-dibenzo[b,e]azepine-10-carboxylic acid methyl ester (see Gijsen, H. J. M.; Berthelot, D.; Zaja, M.; Brône, B.; Geuens, I.; Mercken, M. J. Med. Chem. 2010, 53, 7011). Comparable results were obtained when benzylisothiocyanate (BITC) was used as agonist, which is a less volatile alternative to allylisothiocyanate. Data shown for the rTRPA1 assay, were generated using BITC as agonist. For detailed procedures see supplementary material.
    • (2010) J. Med. Chem. , vol.53 , pp. 7011
    • Gijsen, H.J.M.1    Berthelot, D.2    Zaja, M.3    Brône, B.4    Geuens, I.5    Mercken, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.